Incyte Corporation (INCY)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	3,438,108	3,364,858	3,274,625	3,249,757	3,188,996	3,138,439	3,143,479	2,950,399	2,835,276	2,769,483	2,582,686	2,569,684	2,535,374	2,329,362	2,264,582	2,110,429	2,044,510	1,999,372	1,902,719	1,898,853
Revenue (ttm)	US$ in thousands	3,693,101	3,609,260	3,513,520	3,470,962	3,395,993	3,330,147	3,320,472	3,114,784	2,986,267	2,912,923	2,720,579	2,702,913	2,666,702	2,456,582	2,387,520	2,229,409	2,158,759	2,107,772	2,005,874	1,997,458
Gross profit margin		93.10%	93.23%	93.20%	93.63%	93.90%	94.24%	94.67%	94.72%	94.94%	95.08%	94.93%	95.07%	95.08%	94.82%	94.85%	94.66%	94.71%	94.86%	94.86%	95.06%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $3,438,108K ÷ $3,693,101K
= 93.10%

Over the past eight quarters, Incyte Corp. has maintained consistently high gross profit margins, ranging from 93.10% to 94.72%. This indicates that the company is efficient in managing its production costs and generating revenue from its core business activities. The slight fluctuations in gross profit margin from quarter to quarter are generally within a narrow range, suggesting stability in the company's pricing strategies and cost management practices. Overall, Incyte Corp. demonstrates a strong ability to generate profits from its core operations, reflecting positively on its operational efficiency and overall financial health.